Research ID
hum0113-v1Release info
Research title
Development of metabolite biomarkers of Parkinson's disease and identification of drug seeds from chemical screening based on the biomarkers
Research overview
- Aims
- Identification of RNA biomarkers in Parkinson's disease (PD) patients
- Methods
- Transcriptome sequencing (CAGE-seq)
- Participants/materials
- Whole blood samples from 39 PD patients and 20 non-PD (healthy) controls
iPS-derived neuron cells provided by 2 PD patients with PARK2 mutations and 3 non-PD (healthy) controls
iPS-derived neuronal stem cells (NSC) provided by 2 PD patients with PARK2 mutations and 3 non-PD (healthy) controls - URL
- N/A
Datasets
The list is the one this version published; each dataset's content is shown as it is now.
| Cart | Dataset ID | Type of data | Analysis method | Access criteria | Date published |
|---|---|---|---|---|---|
| JGAD000129 | NGS (CAGE-seq) |
| Controlled-access (Type I) | 2020-09-28 |
Data provider
- Principal investigator
- Piero Carninci
- Affiliation
- RIKEN Center for Integrative Medicine Science, Division of Genomic Medicine
Research projects
No research projects.
Grants
| Name | Title | Project number |
|---|---|---|
Core Research and Evolutional Science and Technology, Advanced Research & Development Programs for Medical Innovation, Japan Agency for Medical Research and Development (AMED-CREST) | Development of metabolite biomarker specific for Parkinson's disease and identification of drug seeds based on its molecular target |
|
Related publications
| Title | DOI | Dataset ID |
|---|---|---|
Multi-year whole-blood transcriptome data for the study of onset and progression of Parkinson's Disease |
Controlled access users
No use of the controlled access data has been recorded.